Abstract
Louise Degenhardt and colleagues discuss the evidence and the debate about whether Global Burden of Disease estimates should include cannabis use as a risk factor for psychosis.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Cannabis / adverse effects*
-
Confounding Factors, Epidemiologic
-
Cost of Illness*
-
Humans
-
Observation
-
Psychotic Disorders / etiology*
-
Risk Assessment / methods
-
Risk Factors
-
Schizophrenia / etiology*